S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)

EyePoint Pharmaceuticals (EYPT) News Today

$23.11
-0.45 (-1.91%)
(As of 12/29/2023 ET)
SourceHeadline
marketbeat.com logoEyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Short Interest Down 32.2% in December
marketbeat.com - December 31 at 12:20 AM
marketbeat.com logoVontobel Holding Ltd. Has $1.41 Million Stock Position in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT)
marketbeat.com - December 25 at 4:21 AM
finance.yahoo.com logoEyePoint Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 20 at 10:32 AM
marketbeat.com logoEyePoint Pharmaceuticals (NASDAQ:EYPT) Trading Down 5% After Insider Selling
marketbeat.com - December 18 at 2:56 PM
finance.yahoo.com logoWhat EyePoint Pharmaceuticals, Inc.'s (NASDAQ:EYPT) 194% Share Price Gain Is Not Telling You
finance.yahoo.com - December 18 at 10:04 AM
msn.com logoEyePoint Pharmaceuticals (EYPT) Price Target Increased by 37.87% to 42.50
msn.com - December 17 at 2:49 AM
marketbeat.com logoInsider Selling: EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Insider Sells 1,458 Shares of Stock
marketbeat.com - December 15 at 7:03 PM
marketbeat.com logoCantor Fitzgerald Comments on EyePoint Pharmaceuticals, Inc.'s FY2023 Earnings (NASDAQ:EYPT)
marketbeat.com - December 14 at 6:48 AM
finance.yahoo.com logoEyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Analysts Just Trimmed Their Revenue Forecasts By 11%
finance.yahoo.com - December 13 at 10:35 AM
marketbeat.com logoEyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) to Post FY2023 Earnings of ($2.27) Per Share, Capital One Financial Forecasts
marketbeat.com - December 13 at 7:29 AM
marketbeat.com logoEyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Major Shareholder Purchases $9,999,995.00 in Stock
marketbeat.com - December 12 at 6:36 PM
msn.com logoCapital One Initiates Coverage of EyePoint Pharmaceuticals (EYPT) with Overweight Recommendation
msn.com - December 11 at 7:34 PM
finance.yahoo.com logoEyePoint Pharmaceuticals (EYPT) is a Great Momentum Stock: Should You Buy?
finance.yahoo.com - December 11 at 2:34 PM
marketbeat.com logoEyePoint Pharmaceuticals (NASDAQ:EYPT) Coverage Initiated by Analysts at Capital One Financial
marketbeat.com - December 11 at 10:21 AM
finance.yahoo.com logoInstitutional investors have a lot riding on EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) with 43% ownership
finance.yahoo.com - December 11 at 9:33 AM
finance.yahoo.com logoEyePoint Pharmaceuticals Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares
finance.yahoo.com - December 8 at 7:28 PM
finance.yahoo.com logoWhat Makes EyePoint Pharmaceuticals (EYPT) a Good Fit for 'Trend Investing'
finance.yahoo.com - December 8 at 2:28 PM
finance.yahoo.com logoWall Street Analysts Believe EyePoint Pharmaceuticals (EYPT) Could Rally 77.05%: Here's is How to Trade
finance.yahoo.com - December 8 at 2:28 PM
benzinga.com logoThis Tech Stock Is 'Too Expensive,' Cramer Says: 'Wait For A Pullback'
benzinga.com - December 8 at 9:28 AM
msn.com logoInsider Trading: EyePoint’s (NASDAQ:EYPT) Insider Makes an Enormous Purchase
msn.com - December 7 at 11:12 PM
finance.yahoo.com logoInsider Sell Alert: Chief Corp Dev. & Strat.
finance.yahoo.com - December 7 at 6:11 PM
finance.yahoo.com logoInsider Sell Alert: Chief Corp Dev. & Strat. ...
finance.yahoo.com - December 7 at 6:11 PM
benzinga.com logoEyePoint Pharmaceuticals Stock (NASDAQ:EYPT) Dividends: History, Yield and Dates
benzinga.com - December 6 at 7:38 PM
markets.businessinsider.com logoBuy Rating Affirmed for EyePoint Pharmaceuticals Following EYP-1901’s Promising Trial Outcomes
markets.businessinsider.com - December 6 at 9:38 AM
msn.com logoEyePoint Pharmaceuticals prices upsized $200 million stock offering
msn.com - December 6 at 9:38 AM
finance.yahoo.com logoEyePoint Pharmaceuticals Announces Pricing of Upsized Public Offering
finance.yahoo.com - December 5 at 11:21 PM
msn.com logoEyePoint data suggest time-released drug may help patients with macular degeneration
msn.com - December 5 at 1:20 PM
finance.yahoo.com logoEyePoint (EYPT) Surges 178% on Upbeat Phase II Eye Disease Data
finance.yahoo.com - December 5 at 1:20 PM
seekingalpha.com logoEyePoint Pharmaceuticals Soaring On Wet AMD Study Results: Durasert Looks Real Deal
seekingalpha.com - December 5 at 10:30 AM
msn.com logoCrude Oil Falls Over 1%; EyePoint Pharmaceuticals Shares Spike Higher
msn.com - December 5 at 8:19 AM
investing.com logoAfter-hours movers: GitLab surges on earnings, EyePoint adds to intra-day gains
investing.com - December 4 at 7:15 PM
msn.com logoEyePoint Pharmaceuticals’ stock soars 200% after company announces positive data for macular degeneration treatment
msn.com - December 4 at 7:15 PM
bizjournals.com logoWatertown biotech shares surge nearly 200% on new drug data
bizjournals.com - December 4 at 2:15 PM
msn.com logoEyePoint Pharmaceuticals’ stock soars 212% after company announces positive data for macular degeneration treatment
msn.com - December 4 at 2:15 PM
marketwatch.com logoEyePoint Pharmaceuticals Phase 2 Macular Degeneration Treatment Trial Shows Positive Results
marketwatch.com - December 4 at 9:14 AM
markets.businessinsider.com logoEyePoint's Phase 2 DAVIO 2 Trial Of EYP-1901 Achieves Primary, Secondary Endpoints In Wet AMD
markets.businessinsider.com - December 4 at 9:14 AM
markets.businessinsider.com logoWhy Is Age-Related Blindness Focused EyePoint Pharmaceuticals Stock Trading Over 300% Today?
markets.businessinsider.com - December 4 at 9:14 AM
finance.yahoo.com logoEyePoint Pharmaceuticals Announces Positive Topline Data from the Phase 2 DAVIO 2 Trial of EYP-1901 in Wet AMD Achieving All Primary and Secondary Endpoints
finance.yahoo.com - December 4 at 9:14 AM
marketbeat.com logo
marketbeat.com - December 4 at 6:57 AM
seekingalpha.com logoShorting EyePoint Pharmaceuticals Ahead Of Davio-2 Wet-AMD Data: Potential 78% Gain
seekingalpha.com - November 30 at 4:39 PM
finance.yahoo.com logoDoes EyePoint Pharmaceuticals (EYPT) Have the Potential to Rally 336.07% as Wall Street Analysts Expect?
finance.yahoo.com - November 21 at 1:39 PM
morningstar.com logoEyePoint Pharmaceuticals Inc EYPT
morningstar.com - November 9 at 9:16 AM
seekingalpha.com logoCountdown To Clarity: EyePoint's December Data Delivery
seekingalpha.com - November 8 at 8:04 AM
finance.yahoo.com logoNeed To Know: Analysts Are Much More Bullish On EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Revenues
finance.yahoo.com - November 3 at 7:25 AM
msn.com logoMizuho Initiates Coverage of EyePoint Pharmaceuticals (EYPT) with Buy Recommendation
msn.com - November 3 at 1:54 AM
markets.businessinsider.com logoExpert Ratings for EyePoint Pharmaceuticals
markets.businessinsider.com - November 2 at 8:53 PM
finance.yahoo.com logoEyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 2 at 8:53 PM
msn.com logoWhy Is Vision Disorder-Focused EyePoint Pharmaceuticals Stock Trading Higher Today?
msn.com - November 1 at 6:04 PM
msn.com logoEyePoint Pharmaceuticals beats Q3 top and bottom line estimates
msn.com - November 1 at 1:04 PM
finance.yahoo.com logoEyePoint Pharmaceuticals Inc (EYPT) Reports Q3 2023 Financial Results
finance.yahoo.com - November 1 at 1:04 PM
Get EyePoint Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for EYPT and its competitors with MarketBeat's FREE daily newsletter.



EYPT Media Mentions By Week

EYPT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

EYPT
News Sentiment

1.61

0.84

Average
Medical
News Sentiment

EYPT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

EYPT Articles
This Week

4

2

EYPT Articles
Average Week

Get EyePoint Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for EYPT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:EYPT) was last updated on 12/31/2023 by MarketBeat.com Staff

My Account -